Solti Breast Cancer Research Group
Clinical trials sponsored by Solti Breast Cancer Research Group, explained in plain language.
-
New drug combo shows promise in shrinking breast tumors before surgery
Disease control Recruiting nowThis study is for premenopausal women with a common type of breast cancer (HR+/HER2-). It tests a drug called elacestrant, given alone or with another drug (triptorelin), for 4 weeks before surgery. The goal is to see if the treatment lowers a marker of cancer growth (Ki67) in th…
Phase: PHASE2 • Sponsor: SOLTI Breast Cancer Research Group • Aim: Disease control
Last updated May 17, 2026 11:53 UTC
-
New drug plus smart monitoring aims to control advanced breast cancer
Disease control Recruiting nowThis study tests a drug called T-DXd as the first treatment for people with HER2-positive breast cancer that has spread. About 300 participants will receive the drug and use digital tools to track side effects, especially lung issues. The goal is to see how long the drug keeps th…
Phase: PHASE2 • Sponsor: SOLTI Breast Cancer Research Group • Aim: Disease control
Last updated May 04, 2026 16:21 UTC